Pyridyloxypropanolamines L-749,372 (8, beta(3) EC50 = 3.6 nM) and L-75
0,355 (29, beta(3) EC50 = 13 nM) are selective partial agonists of the
human receptor, with 33% and 49% activation, respectively. Both stimu
late lipolysis in rhesus monkeys (ED50 = 2 and 0.8 mg/kg, respectively
), with minimal effects on heart rate. Oral bioavailability in dogs, 4
1% for L-749,372 and 47% for L-750,355, is improved relative to phenol
analogs. (C) 1998 Elsevier Science Ltd. All rights reserved.